These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 10331967)
1. Trisomy 8 in stage I and stage III ovarian cancer detected by fluorescence in situ hybridization. Mark HF; Afify AM; Werness BA; Das S; Mark S; Samy M Exp Mol Pathol; 1999 Apr; 66(1):76-81. PubMed ID: 10331967 [TBL] [Abstract][Full Text] [Related]
2. HER-2/neu oncogene amplification in stage I and stage III ovarian papillary serous carcinoma. Afify AM; Werness BA; Mark HF Exp Mol Pathol; 1999 Jun; 66(2):163-9. PubMed ID: 10409445 [TBL] [Abstract][Full Text] [Related]
3. Assessment of chromosome 8 copy number in cervical cancer by fluorescent in situ hybridization. Mark HF; Feldman D; Samy M; Sun C; Das S; Mark S; Lathrop J Exp Mol Pathol; 1999 Jun; 66(2):157-62. PubMed ID: 10409444 [TBL] [Abstract][Full Text] [Related]
4. Assessment of chromosomal trisomies in prostate cancer using fluorescent in situ hybridization. Mark HF; Feldman D; Das S; Samy M; Sun CL; Mark S Exp Mol Pathol; 1999 Oct; 67(2):109-17. PubMed ID: 10527762 [TBL] [Abstract][Full Text] [Related]
5. [Detection of chromosome 8 anomalies in ovarian carcinoma by fluorescence in situ hybridization]. Dong YL; Li CH; Chen LX; Feng HY; Zhu BS Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):59-60. PubMed ID: 12579504 [TBL] [Abstract][Full Text] [Related]
6. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma. Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838 [TBL] [Abstract][Full Text] [Related]
7. [Detection of extra chromosomes 12 by fluorescent in situ hybridization (FISH) in ovarian stromal tumors. Study of 12 cases and review of the literature]. Gancberg D; Scourneau M; Verdebout JM; Larsimont D; Verhest A Ann Pathol; 2001 Oct; 21(5):393-8. PubMed ID: 11852357 [TBL] [Abstract][Full Text] [Related]
8. Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage. Partheen K; Levan K; Osterberg L; Helou K; Horvath G Genes Chromosomes Cancer; 2004 Aug; 40(4):342-8. PubMed ID: 15188458 [TBL] [Abstract][Full Text] [Related]
9. Interphase fluorescence in situ hybridization studies of ovarian adenocarcinomas using the midisatellite probe. Kalir T; Eisberg A; Dottino P; Cohen C Gynecol Oncol; 1999 Feb; 72(2):208-14. PubMed ID: 10021303 [TBL] [Abstract][Full Text] [Related]
10. Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization. Mendelin J; Grayson M; Wallis T; Visscher DW Lab Invest; 1999 Apr; 79(4):387-93. PubMed ID: 10211991 [TBL] [Abstract][Full Text] [Related]
11. ERBB2 and chromosome 17 centromere studies of ovarian cancer by fluorescence in situ hybridization. Young SR; Liu WH; Brock JA; Smith ST Genes Chromosomes Cancer; 1996 Jun; 16(2):130-7. PubMed ID: 8818660 [TBL] [Abstract][Full Text] [Related]
12. Detection of trisomy 12 on ovarian sex cord stromal tumors by fluorescence in situ hybridization. Taruscio D; Carcangiu ML; Ward DC Diagn Mol Pathol; 1993 Jun; 2(2):94-8. PubMed ID: 8269283 [TBL] [Abstract][Full Text] [Related]
13. Numerical chromosomal aberrations in borderline, benign, and malignant epithelial tumors of the ovary: correlation with p53 protein overexpression and Ki-67. Kohlberger PD; Kieback DG; Mian C; Wiener H; Kainz C; Gitsch G; Breitenecker G J Soc Gynecol Investig; 1997; 4(5):262-4. PubMed ID: 9360232 [TBL] [Abstract][Full Text] [Related]
14. Interphase fluorescence in situ hybridization for trisomy 12 on archival ovarian sex cord-stromal tumors. Shashi V; Golden WL; von Kap-Herr C; Andersen WA; Gaffey MJ Gynecol Oncol; 1994 Dec; 55(3 Pt 1):349-54. PubMed ID: 7835773 [TBL] [Abstract][Full Text] [Related]
15. [Oncogene ZNF217 amplification on chromosome 20 q in ovarian serous cystadenocarcinoma and its clinical implications]. Li J; Zhong M; Song LL; Su GD Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):824-5. PubMed ID: 16793610 [TBL] [Abstract][Full Text] [Related]
16. Early involvement of 6q in surface epithelial ovarian tumors. Tibiletti MG; Bernasconi B; Furlan D; Riva C; Trubia M; Buraggi G; Franchi M; Bolis P; Mariani A; Frigerio L; Capella C; Taramelli R Cancer Res; 1996 Oct; 56(19):4493-8. PubMed ID: 8813146 [TBL] [Abstract][Full Text] [Related]
17. Association of 20q13.2 copy number changes with the advanced stage of ovarian cancer-tissue microarray analysis. Dimova I; Yosifova A; Zaharieva B; Raitcheva S; Doganov N; Toncheva D Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):81-5. PubMed ID: 15596278 [TBL] [Abstract][Full Text] [Related]
18. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours. Evans MF; McDicken IW; Herrington CS J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488 [TBL] [Abstract][Full Text] [Related]
19. [ZNF217 gene was detected in ovarian serous cystadenocarcinoma by fluorescence in situ hybridization]. Zhong M; Li J; Ding YQ; Song LL Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):665-7. PubMed ID: 17160949 [TBL] [Abstract][Full Text] [Related]
20. [Detection of abnormal numbers of chromosome 8 with interphase fluorescence in situ hybridization in hematologic malignancies]. Wang HP; Li GX; Qiao ZH; Wang HW Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):395-7. PubMed ID: 15300644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]